ST. LOUIS, Missouri — August 17, 2026 — Medinexo, a global healthcare communications network connecting participants across the healthcare and clinical research ecosystem, today announced the launch of ResearchNexo IQ, an AI-powered research and intelligence platform made available to Medinexo members through a partnership with Innovo Health Labs.

ResearchNexo IQ is purpose-built to help clinical research ecosystem participants conduct complex research faster and more efficiently. Instead of relying on a single general-purpose AI model, the platform coordinates a team of specialized AI agents, each designed for specific research functions and connected to authoritative scientific, clinical, regulatory, intellectual property, and market data sources.

Medinexo members will receive complimentary ResearchNexo IQ credits every month as part of their membership, giving healthcare professionals, research sites, sponsors, CROs, biotechnology and pharmaceutical companies, medical device organizations, and other research stakeholders access to advanced research capabilities without the traditional cost and time associated with many manual research workflows.

Research That Can Be Traced Back to the Source

ResearchNexo IQ is designed around a simple principle: research used to make important decisions should be source-attributed, transparent, and auditable.

Users describe a research task in plain language, and ResearchNexo IQ identifies and coordinates the appropriate AI specialists. Those specialists work across dedicated authoritative data sources and synthesize their findings into structured, business-ready deliverables with citations that users can trace back to the underlying source records.

The platform currently provides access to 30+ AI specialists, 50+ authoritative data sources, and 20+ continuously updated Radar intelligence boards. ResearchNexo IQ supports both Co-Pilot Mode, in which users can review and guide the specialist team and research plan, and Autopilot Mode, which handles the workflow end-to-end.

“Clinical research organizations and healthcare professionals spend an extraordinary amount of time finding, reviewing, validating, and organizing information before they can act on it,” said Jorge H. Toro, President & Founder of Medinexo said “ResearchNexo IQ gives our members a new way to compress that work. More importantly, it is designed to provide research they can trace back to the underlying sources. By making this capability part of Medinexo membership, we are continuing our mission of removing barriers to technology and innovation throughout the global healthcare community.”

AI Specialists Built Around Real Clinical Research Workflows

ResearchNexo IQ supports a broad range of workflows across clinical research, life sciences, MedTech, and healthcare, including:

• Clinical evidence and literature research — cited literature briefs, systematic evidence summaries, trial landscapes, and drug information dossiers.

• Clinical trial intelligence — trial design and endpoint research, investigator and site intelligence, and recruiting-site landscapes.

• Regulatory research — FDA and global regulatory pathway intelligence, including support for drug and medical-device research.

• Intellectual property research — patent landscapes, freedom-to-operate research, and drug patent/IP assessments.

• KOL and investigator intelligence — identification and ranking of relevant experts using publication, clinical-trial, and disclosure data.

• Medical and scientific writing — structured research and evidence to support documents including investigator’s brochures, clinical evaluation reports, protocols, and other research deliverables.

• Claims and commercialization research — evidence-backed claims research, competitor analyses, ingredient safety reviews, and geographic regulatory pathway intelligence.

• Ongoing intelligence monitoring — Radar boards covering medical conferences, device and regulatory activity, pharmaceutical markets, patent cliffs, emerging biotechnology companies, recalls, and other areas.

ResearchNexo IQ draws from sources including PubMed, ClinicalTrials.gov, FDA databases, USPTO and EPO patent data, CMS Open Payments, DailyMed, PubChem, EMA resources, CrossRef, and other authoritative datasets. (Medinexo)

Turning Hours of Research Into Actionable Intelligence

The partnership addresses one of the most persistent challenges across the clinical research ecosystem: highly skilled professionals spending significant amounts of time searching fragmented databases, reconciling information, validating sources, and assembling findings into usable documents.

ResearchNexo IQ is intended to reduce that burden by allowing specialized AI agents to perform research tasks in parallel and return structured, cited deliverables. This can help organizations reduce time and research costs while enabling their teams to focus more of their effort on scientific, clinical, operational, and strategic decisions.

Innovo Health Labs develops AI specialist infrastructure for healthcare, wellness, and life sciences, connecting authoritative health datasets and purpose-built AI specialists for areas including clinical evidence, patents, regulatory intelligence, KOL mapping, drug research, and medical writing.

Complimentary Credits for Medinexo Members

As part of the launch, eligible Medinexo members receive 650 complimentary ResearchNexo IQ credits during their first month, consisting of a 500-credit launch bonus plus the standard 150 monthly credits.

Beginning in the second month, membership includes 150 complimentary ResearchNexo IQ credits each month, renewed automatically at no additional charge.

The credits allow members to explore ResearchNexo IQ and apply its AI specialists to their own research needs, from targeted literature reviews and investigator searches to regulatory intelligence, trial landscapes, patent research, and more.

Extending Medinexo’s Mission

Medinexo provides technology and services to participants throughout the global healthcare community, with a focus on reducing barriers to technology and innovation and expanding participation in clinical research. Its ResearchNexo services support research sites and other stakeholders with tools, training, research readiness, sponsor connectivity, and access to clinical research opportunities.

The introduction of ResearchNexo IQ expands that mission into AI-powered research intelligence, giving Medinexo members a new set of tools to find evidence, evaluate opportunities, prepare research, and make better-informed decisions.

Availability

ResearchNexo IQ is available now to Medinexo members. Members can log in to Medinexo to access their complimentary credits and begin using the platform.

For additional information about ResearchNexo IQ, its AI specialists, available research workflows, and the Medinexo member credit program, visit the ResearchNexo IQ member announcement page.

About Medinexo

Medinexo is a global healthcare communications network providing technology and services to participants throughout the healthcare community. Through its ResearchNexo platform and global network, Medinexo works to reduce barriers to clinical research participation, connect research sites and healthcare professionals with sponsors and industry stakeholders, and accelerate access to healthcare innovation.

For more information, visit Medinexo.com.

For more information, visit InnovoHealthLabs.com.

Media Contact

Medinexo
Jorge H. Toro
jorgetoro@medinexo.com

ResearchNexo IQ aggregates publicly available, source-attributed data and provides decision-support intelligence. It is not legal, medical, or investment advice. Third-party source databases remain the property of their respective owners.